
"When Prof. Calogero Caruso of the University of Palermo, Italy, founded Immunity & Ageing 20 years ago, the journal was a pioneer in two distinct ways. First, it was an early adopter of the Open Access academic publishing concept as a member of the stable of journals established by the visionary Vitek Tracz in London, UK, in 2000 (BioMed Central, deriving from the original notion of PubMed providing open access to scientific publications). Second, it focused exclusively on the impact of ageing on immunity and vice versa at a time in the development of the field when there was relatively little interest in this topic. Thus, for example, searching for “immunosenescence” in PubMed yields 36 hits for papers published in 2003, whereas 20 years later this number is >300. The influence of I&A and the field is reflected in the increasing numbers of submissions to the journal and citations of published papers, with a first 2-year Clarivate impact factor of 2.3 in 2013, peaking at 9.7 in 2021. It has been my privilege and pleasure to have helped guide the Journal over the entire 20 years of its existence, first as Deputy Editor to Prof Caruso until 2018, then as Co-Editor-in-Chief with Dr Nan-Ping Weng, NIA, Baltimore, USA (2019-2023) and currently with Prof. Daniela Frasca (University of Miami). The support and encouragement of the I&A journal management team, led by Dr. Britta Müller (Heidelberg) since 2019, has been instrumental in ensuring the success of the journal, which I firmly believe will continue to be influential over the next 20 years."
– Prof Graham Pawelec, Co-Editor-in-Chief, University of Tübingen, Germany
Comments from our community
"When Prof. Calogero Caruso of the University of Palermo, Italy, founded Immunity & Ageing 20 years ago, the journal was a pioneer in two distinct ways. First, it was an early adopter of the Open Access academic publishing concept as a member of the stable of journals established by the visionary Vitek Tracz in London, UK, in 2000 (BioMed Central, deriving from the original notion of PubMed providing open access to scientific publications). Second, it focused exclusively on the impact of ageing on immunity and vice versa at a time in the development of the field when there was relatively little interest in this topic. Thus, for example, searching for “immunosenescence” in PubMed yields 36 hits for papers published in 2003, whereas 20 years later this number is >300. The influence of I&A and the field is reflected in the increasing numbers of submissions to the journal and citations of published papers, with a first 2-year Clarivate impact factor of 2.3 in 2013, peaking at 9.7 in 2021. It has been my privilege and pleasure to have helped guide the Journal over the entire 20 years of its existence, first as Deputy Editor to Prof Caruso until 2018, then as Co-Editor-in-Chief with Dr Nan-Ping Weng, NIA, Baltimore, USA (2019-2023) and currently with Prof. Daniela Frasca (University of Miami). The support and encouragement of the I&A journal management team, led by Dr. Britta Müller (Heidelberg) since 2019, has been instrumental in ensuring the success of the journal, which I firmly believe will continue to be influential over the next 20 years."
– Prof Graham Pawelec, Co-Editor-in-Chief, University of Tübingen, Germany